SG
DARE icon

StoneX Group’s Dare Bioscience DARE Stock Holding History

StoneX Group’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.7K Buy
+11,153
New +$24.9K ﹤0.01% 1294

Other funds holding DARE

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $91.6B AUM 29.2% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

StoneX Group's DARE Position: Q2 2026 in Review

StoneX Group opened a new position in Dare Bioscience (DARE) in Q2 2026: 11,153 shares worth $24.7K. The stake represents ﹤0.01% of the portfolio and ranks #1294 among its holdings.

27 funds tracked by Wall St. Rank hold DARE as of Q2 2026.

  • StoneX Group held 11,153 shares of Dare Bioscience worth $24.7K as of Q2 2026.
  • Dare Bioscience was a new StoneX Group position in Q2 2026.
  • Dare Bioscience made up ﹤0.01% of StoneX Group's portfolio in Q2 2026, its #1294 holding.
  • 27 funds tracked by Wall St. Rank held Dare Bioscience as of Q2 2026.

Based on StoneX Group's 13F filing for Q2 2026, filed 12 Aug 2026.